Comparison of high- and low-dose 4-factor prothrombin complex concentrate for the emergent reversal of oral Factor Xa inhibitors
Crossref DOI link: https://doi.org/10.1007/s11239-021-02412-8
Published Online: 2021-03-16
Published Print: 2021-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hormese, Mary http://orcid.org/0000-0002-2304-4749
Littler, Alex
Doane, Brian
Glowacki, Nicole
Khimani, Ann
Vivacqua, Nicole
Rudenberg, Karina
Text and Data Mining valid from 2021-03-16
Version of Record valid from 2021-03-16
Article History
Accepted: 16 February 2021
First Online: 16 March 2021